Trial intelligence / Profile preview

IVMTX vs ITMTX for CNS Prophylaxis in DLBCL

NCT03123718Phase 3Unknown

Sponsor
Chonnam National University Hospital
Start
Jul 2017
Primary completion
Jun 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methotrexate in diffuse large B-cell lymphoma (DLBCL), sponsored by Chonnam National University Hospital. Status: unknown.

02

Drugs

methotrexate
03

Conditions

diffuse large B-cell lymphoma (DLBCL)

Beyond the preview

Go deeper on NCT03123718.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03123718.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call